U.S. Senate votes to delay hemp product deadline to December

The U.S. Senate has voted to potentially delay the federal deadline for certain hemp-based products from November 12 to December 11. The extension specifically applies to non-synthetic cannabinoid products, such as delta-8, delta-10, and THCP, which the plant can produce naturally. However, the deadline for cannabinoids treated as synthetic—those incapable of being naturally produced by a Cannabis sativa L. plant—remains unchanged for November 12.

The delay is part of a stopgap funding bill intended to prevent a government shutdown. The measure now awaits adoption by the House of Representatives. If passed, the extension would move the container threshold and the out-of-plant synthesis exclusion for naturally occurring cannabinoids to December.

Industry advocates, including representatives from Cornbread Hemp and the National Restaurant Association, have expressed support for the delay, citing the need for a sensible regulatory framework. The National Restaurant Association noted that the THC beverage market represents a $1.6 billion opportunity for the foodservice sector. Conversely, Senator Ted Budd opposed the motion, arguing that the delay protects an industry selling intoxicants marketed toward children.